A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction
Clinical trial NCT07091929 · COMPLETED
Trial details
- NCT number
- NCT07091929
- Sponsor
- Beijing Sungen Biomedical Technology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-20
- Primary completion
- 2025-07-18
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.